Neuralstem to raise $19.7 million in direct offering

Stem cell company Neuralstem Inc. (NYSE-M:CUR) proposed to raise $19.7 million through the sale of 6.8 million shares at $2.91 in a registered direct offering to institutional investors. The price is ...